Skip to main content

Russell Investments Group, Ltd.

Position in URGN — UroGen Pharma Ltd.

CIK 1692234 Seattle, WA

Position in URGN

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,137,161
+$30,405 QoQ
Shares Held
63,246
+33.8% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,224,048,594 across 266 Biotechnology names. URGN ranks #93 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in URGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,137,161 63,246
2025-12-31 $1,106,756 47,257
2025-09-30 $66,253 3,321
2025-06-30 $2,685 196
2024-09-30 $3,213 253
2024-06-30 $4,245 253
2024-03-31 $3,795 253
2023-12-31 $3,795 253
2023-09-30 $3,544 253
2023-06-30 $2,618 253
2023-03-31 $2,337 253
2022-06-30 $16,068 1,962
2022-03-31 $17,089 1,962
2021-12-31 $18,658 1,962
2021-09-30 $958,688 56,997
2021-06-30 $868,495 56,876
2021-03-31 $661,403 33,953
2020-12-31 $1,031,122 57,221